ARCHIVES

FDA Advisory Committee Recommends Approval Of Ifosfamide as Third Line Therapy For Testicular Cancer

This article is from The Cancer Letter archive.

Vol. 14 No. 18 | April 29, 1988

Download PDF Visit The Full Archive

Related Articles

NCAB Subcommittee Calls For Review Of Organ Site Program, Consideration Of One For Lung Cancer

May 1, 1981

FCRC Committee Limited To Review Of Basic Science

November 26, 1976

Avastin Improves PFS For Metastatic Colorectal Cancer In Phase III Study

February 23, 2007

Diet Intervention Results Could Be Found In Months

April 4, 1986

Generic Drug Makers Set Sights In Taxol Worldwide Market

April 2, 1993

Bisphosphonates May Reduce Recurrent Breast Cancer

December 25, 2009